Casarubinstein taybi genereviews

Identification of de novo EP300 and PLAU variants in a patient

Por um escritor misterioso
Last updated 26 abril 2025
Identification of de novo EP300 and PLAU variants in a patient
Identification of de novo EP300 and PLAU variants in a patient
PDF) Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patients
Identification of de novo EP300 and PLAU variants in a patient
Variants in SMC3 and SMC1A identified in patients with CdLS (CdLS-1 and
Identification of de novo EP300 and PLAU variants in a patient
Rbfox2 undergoes changes in HLHS patient hearts.: (a) The effect of de
Identification of de novo EP300 and PLAU variants in a patient
Mutations truncating the EP300 acetylase in human cancers
Identification of de novo EP300 and PLAU variants in a patient
Biomolecules, Free Full-Text
Identification of de novo EP300 and PLAU variants in a patient
Identification of novel nutrient-sensitive gene regulatory networks in amniotic fluid from fetuses with spina bifida using miRNA and transcription factor network analysis
Identification of de novo EP300 and PLAU variants in a patient
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
Identification of de novo EP300 and PLAU variants in a patient
Identification of de novo EP300 and PLAU variants in a patient with Rubinstein–Taybi syndrome-related arterial vasculopathy and skeletal anomaly
Identification of de novo EP300 and PLAU variants in a patient
Cancers, Free Full-Text
Identification of de novo EP300 and PLAU variants in a patient
Base-pair level characterization of clinically-identified de novo
Recomendado para você
você pode gostar

© 2014-2025 progresstn.com. All rights reserved.